P576: A PHASE I/II STUDY OF MILADEMETAN (DS3032B) IN COMBINATION WITH LOW DOSE CYTARABINE WITH OR WITHOUT VENETOCLAX IN ACUTE MYELOID LEUKEMIA.

Authors :: Senapati, J.
Ishizawa, J.
Abbas, H. A.
Loghavi, S.
Borthakur, G.
Issa, G. C.
Dara, S. I.
Pourebrahim, R.
Daver, N.
Jabbour, E. J.
Kornblau, S. M.
Pemmaraju, N.
Garcia‐Manero, G.
Ravandi, F.
Muftuoglu, M.
Khoury, J.
DiNardo, C.
Andreeff, M.
Source :: HemaSphere; 2022 Supplement 3, Vol. 6, p475-476, 2p
Publication Year :: 2022

Full Text Access

Tools